Board of directors (10)
Directors with a Section 16 filing in the last 13 months. “Since” is the first filing as a director; SEC data sets start in 2016.
Executive officers (5)
Company facts
- Chair
- —
- In S&P 500 since
- Sep 2016
- Incorporated in
- DE
- Fiscal year ends
- October
- SEC industry
- Ophthalmic Goods
- SEC filings
- EDGAR
Major holders (5% or more)
Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.
No 5% holder filings parsed yet for this company.
Insider trades
Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 16, 2026 | Lawrence Erik Kurzius Director | Buy | 10,000 | $54.93 | $549K |
| Sep 14, 2026 | Walter M. Rosebrough, Jr. Director | Buy | 3,000 | $54.29 | $163K |
| Sep 14, 2026 | Lawrence Erik Kurzius Director | Buy | 10,000 | $53.92 | $539K |
| Sep 11, 2026 | Paul A. Keel Director | Buy | 4,701 | $53.18 | $250K |
| Sep 11, 2026 | Walter M. Rosebrough, Jr. Director | Buy | 7,000 | $54.11 | $379K |
| Dec 22, 2025 | Cynthia L. Lucchese Director | Buy | 1,784 | $84.06 | $150K |
| Dec 18, 2025 | Maria Rivas Director | Buy | 1,000 | $82.13 | $82K |
| Dec 17, 2025 | Lawrence Erik Kurzius Director | Buy | 2,000 | $82.50 | $165K |
| Dec 16, 2025 | Holly R. Sheffield President, CSI | Buy | 1,230 | $80.75 | $99K |
| Dec 16, 2025 | Albert G. White III President & CEO | Buy | 10,000 | $80.80 | $808K |
| Sep 29, 2025 | Lawrence Erik Kurzius Director | Buy | 2,000 | $68.39 | $137K |
| Sep 5, 2025 | Albert G. White III President & CEO | Buy | 10,000 | $68.39 | $684K |
| Sep 5, 2025 | Gerard H. Warner III President, CooperVision, Inc. | Buy | 1,450 | $69.23 | $100K |
| Sep 2, 2025 | Daniel G. McBride EVP & Chief Operating Officer | Buy | 3,000 | $65.04 | $195K |
| Sep 2, 2025 | Brian G. Andrews EVP, CFO & Treasurer | Buy | 1,525 | $65.68 | $100K |
| Sep 19, 2024 | Albert G. White III President & CEO | Sale | 5,995 | $111.36 | $668K |
| Sep 19, 2024 | Albert G. White III President & CEO | Sale | 108,997 | $110.48 | $12.0M |
| Sep 10, 2024 | Agostino Ricupati SVP & CAO | Sale | 1,601 | $108.03 | $173K |
| Sep 5, 2024 | Brian G. Andrews EVP, CFO & Treasurer | Sale | 24,788 | $105.90 | $2.6M |
| Sep 4, 2024 | Daniel G. McBride EVP & Chief Operating Officer | Sale | 900 | $107.00 | $96K |
| Sep 4, 2024 | Daniel G. McBride EVP & Chief Operating Officer | Sale | 87,537 | $105.21 | $9.2M |
| Sep 4, 2024 | Daniel G. McBride EVP & Chief Operating Officer | Sale | 26,555 | $106.33 | $2.8M |
| Mar 18, 2024 | Agostino Ricupati SVP & CAO | Sale | 21,412 | $100.89 | $2.2M |
| Mar 18, 2024 | Agostino Ricupati SVP & CAO | Sale | 3,244 | $100.89 | $327K |
| Mar 18, 2024 | Agostino Ricupati SVP & CAO | Sale | 488 | $100.89 | $49K |
Board and executive changes
Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.
- Oct 27, 2026
Departure of President and Chief Executive Officer On October 27, 2026, Albert G. White III resigned from the Board of Directors (the “Board”) of The Cooper Companies, Inc. (the “Company”) and he ceased serving in the offices of President and Chief Executive Officer of the Company. Mr. White has agreed to remain employed full time as a strategic advisor to the Company through April 1, 2027 to assist in the transition of his responsibilities. Mr. White will receive the payments and benefits to which he is entitled under his Executive Employment Agreement with the Company, dated March 19, 2024, as described under the caption “Quantification of Potential Payments” in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (the “SEC”) on February 24, 2026 (the “Proxy Statement”), which description is incorporated herein by reference.
Read the 8-K filing - May 4, 2026
On May 4, 2026, The Cooper Companies, Inc. (the “Company”) announced that, on recommendation of the Corporate Governance & Nominating Committee, the Board of Directors of the Company (the “Board”) approved an increase in the size of the Board from nine directors to ten directors effective as of July 1, 2026, and approved the appointment of Paul Keel to fill the new director position, effective as of July 1, 2026, until his successor is duly elected and qualified or until his earlier resignation or removal. The Board also approved the appointment of Mr. Keel to the Audit Committee, effective as of July 1, 2026, and concurrent with his appointment to the Board. Mr. Keel has been determined to be an independent director under Nasdaq listing standards. There are no arrangements or understandings between Mr. Keel and any other persons pursuant to which he was selected as a director.
Read the 8-K filing - Dec 23, 2025
The information in Item 1.01 is incorporated by reference herein. In connection with the Agreement, following the recommendation of the Nominating Committee, on December 22, 2025, the Board appointed Mr. Rosebrough to the Board and to the Nominating Committee, effective January 3, 2026. Mr. Rosebrough will be paid the same compensation received by other non-management directors on the Board, which is more fully described under the caption “Compensation of Directors” in the Company’s proxy statement on Schedule 14A filed with the Securities and Exchange Commission on February 19, 2025, as may be adjusted by the Board from time to time. Other than the Agreement, there is no other arrangement or understanding pursuant to which Mr. Rosebrough will be appointed as a director of the Company. There are no family relationships between Mr.
Read the 8-K filing - Dec 12, 2025
On December 9, 2025, Brian G. Andrews, Executive Vice President, Chief Financial Officer and Treasurer of The Cooper Companies, Inc. (the “Company”), assumed the role of principal accounting officer of the Company from Agostino Ricupati, who will continue in the role of the Company’s Senior Vice President, Tax. Mr. Andrews has served as the Company’s Executive Vice President since 2020 and Chief Financial Officer and Treasurer since 2018. Additional biographical information regarding Mr. Andrews is included in the Company’s most recent proxy statement, filed with the Securities and Exchange Commission on February 19, 2025. There are no arrangements or understandings between Mr. Andrews and any other persons pursuant to which he assumed the additional responsibilities of principal accounting officer.
Read the 8-K filing - Dec 4, 2025
On December 4, 2025, Robert S. Weiss, Chairman of the Board (“Chairman”) and a member of the Board of Directors (the “Board”) of The Cooper Companies, Inc. (the “Company”), notified the Company of his resignation as Chairman, effective as of January 2, 2026. Mr. Weiss’ resignation as Chairman was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices. Mr. Weiss will continue to serve as a member of the Board following his resignation as Chairman and will stand for reelection at the Company’s 2026 Annual Meeting of Stockholders. The Board appointed Colleen E. Jay as Chairman, effective immediately following the resignation of Mr. Weiss as Chairman on January 2, 2026. Ms. Jay has served as a member of the Board since 2016 and is currently the Chairman of the Organization & Compensation Committee.
Read the 8-K filing - Apr 30, 2025
On April 30, 2025, The Cooper Companies, Inc. (the “Company”) announced that, on recommendation of the Corporate Governance & Nominating Committee, the Board of Directors of the Company (the “Board”) voted to expand the size of the Board from seven directors to eight directors with effect from May 1, 2025 and to appoint Barbara Carbone to fill the new director position, with effect from May 1, 2025, until her successor is duly elected and qualified or her earlier resignation or removal. Concurrent with her appointment, Ms. Carbone was appointed to the Audit Committee. Ms. Carbone has been determined to be an independent director under Nasdaq listing standards. There are no arrangements or understandings between Ms. Carbone and any other persons pursuant to which she was selected as a director. Additionally, there are no transactions involving the Company and Ms.
Read the 8-K filing - Feb 5, 2025
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. On January 31, 2025, William A. Kozy informed the Board of Directors (the "Board") that he will retire as a director, effective on the date of The Cooper Companies, Inc.'s (the "Company's") next Annual Meeting of Stockholders in April 2025 (the "Annual Meeting"). There are no disagreements between Mr. Kozy and the Company on any matter relating to the Company's operations, policies or practices.
Read the 8-K filing - Dec 14, 2023
On December 12, 2023, Gary S. Petersmeyer informed the Board that he will retire as a director, effective on the date of the Company's next Annual Meeting of Stockholders in March 2024. There are no disagreements between Mr. Petersmeyer and the Company on any matter relating to the Company's operations, policies or practices.
Read the 8-K filing - Nov 30, 2023
On November 30, 2023, The Cooper Companies, Inc. (the “Company”) announced that, on recommendation of the Corporate Governance & Nominating Committee, the Board of Directors of the Company (the “Board”) voted to expand the size of the Board from eight directors to nine directors with effect from December 1, 2023 and to appoint Lawrence E. Kurzius to fill the new director position, with effect from December 1, 2023, until his successor is duly elected and qualified or his earlier resignation or removal. Concurrent with his appointment, Mr. Kurzius was appointed to the Audit Committee and to the Organization & Compensation Committee. Mr. Kurzius has been determined to be an independent director under Nasdaq listing standards. There are no arrangements or understandings between Mr. Kurzius and any other persons pursuant to which he was selected as a director.
Read the 8-K filing - Dec 19, 2022
2023 Incentive Payment Plan On December 13, 2022, the Organization and Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of The Cooper Companies, Inc. (“Cooper”) approved the 2023 Incentive Payment Plan (the “2023 IPP”) for Cooper and its subsidiaries (collectively with Cooper, the “Company”). The 2023 IPP provides cash incentive opportunities for named executive officers and other executives as a percentage of base salaries, based on performance goals relating to the operating business’ (CooperVision’s or CooperSurgical’s) or the Company’s consolidated results (depending upon the named participant’s area of responsibility) and achievement of non-financial goals. The above summary of the 2023 IPP is qualified in its entirety by the copy of such plan attached hereto as Exhibit 10.1 and incorporated herein by reference.
Read the 8-K filing - Oct 4, 2022
On October 3, 2022, The Cooper Companies, Inc. (the “Company”) announced that, on recommendation of the Corporate Governance & Nominating Committee, the Board of Directors of the Company (the “Board”) voted to expand the size of the Board from 8 directors to 9 directors with effect from October 1, 2022 and to elect Cynthia L. Lucchese to fill the new director position, with effect from October 1, 2022, until her successor is duly elected and qualified or her earlier resignation or removal. Concurrent with her election, Ms. Lucchese was appointed to the Audit and the Corporate Governance & Nominating Committees. Ms. Lucchese has been determined to be an independent director under New York Stock Exchange listing standards. There are no arrangements or understandings between Ms. Lucchese and any other persons pursuant to which she was selected as a director.
Read the 8-K filing - Dec 10, 2021
2022 Incentive Payment Plan On December 7, 2021, the Organization and Compensation Committee (the “Committee”) of the Board of Directors of The Cooper Companies, Inc. (“Cooper”) approved the 2022 Incentive Payment Plan (the “2022 IPP”) for Cooper and its subsidiaries (collectively with Cooper, the “Company”) which provides cash incentive opportunities for named executive officers and other executives as a percentage of base salaries, performance goals relating to the operating business’ (CooperVision’s or CooperSurgical’s) or the Company’s consolidated results (depending upon the named participant’s area of responsibility), and achievement of non-financial goals. The above summary of the 2022 IPP is qualified in its entirety by the copy of such plan attached hereto as Exhibit 10.1 and incorporated herein by reference.
Read the 8-K filing - May 12, 2021
On May 12, 2021, The Cooper Companies, Inc. (the “Company”) announced that, on recommendation of the Corporate Governance & Nominating Committee, the Board of Directors of the Company (the “Board”) voted to expand the size of the Board from 7 directors to 8 directors with effect from July 1, 2021 and to elect Maria Rivas, MD to fill the new director position, with effect from July 1, 2021, until her successor is duly elected and qualified or her earlier resignation or removal. Dr. Rivas has been determined to be an independent director under New York Stock Exchange listing standards. There are no arrangements or understandings between Dr. Rivas and any other persons pursuant to which she was selected as a director. Additionally, there are no transactions involving the Company and Dr. Rivas that the Company would be required to report pursuant to Item 404(a) of Regulation S-K. Dr.
Read the 8-K filing - Feb 2, 2021
2021 Incentive Payment Plan On January 28, 2021, the Organization and Compensation Committee (the “Committee”) of the Board of Directors of The Cooper Companies, Inc. (“Cooper”) approved the 2021 Incentive Payment Plan (the “2021 IPP”) for Cooper and its subsidiaries (collectively with Cooper, the “Company”) which provides cash incentive opportunities for named executive officers and other executives as a percentage of base salaries, performance goals relating to the operating business’ (CooperVision’s or CooperSurgical’s) or the Company’s consolidated results (depending upon the named participant’s area of responsibility). The above summary of the 2021 IPP is qualified in its entirety by the copy of such plan attached hereto as Exhibit 10.1 and incorporated herein by reference.
Read the 8-K filing - Dec 10, 2020
On December 10, 2020, The Cooper Companies, Inc. (the “Company”) announced that on December 8, 2020 A. Thomas Bender informed the Board that he will retire as Chairman of the Board and as a director, and Allan E. Rubenstein, M.D. informed the Board that he will retire as Vice Chairman and Lead Director of the Board and as a director, each effective on the date of the Company’s next Annual Meeting of Stockholders in March 2021. There are no disagreements between either Mr. Bender or Dr. Rubenstein and the Company on any matter relating to the Company’s operations, policies or practices.
Read the 8-K filing
Show 12 older changes
- Nov 12, 2020
On November 12, 2020, The Cooper Companies, Inc. (the “Company”) announced that, on recommendation of the Corporate Governance & Nominating Committee, the Board of Directors of the Company (the “Board”) voted to expand the size of the Board from 8 directors to 9 directors with effect from December 1, 2020 and to elect Teresa S. Madden to fill the new director position, with effect from December 1, 2020, until her successor is duly elected and qualified or her earlier resignation or removal. Ms. Madden has been determined to be an independent director under New York Stock Exchange listing standards. There are no arrangements or understandings between Ms. Madden and any other persons pursuant to which she was selected as a director. Additionally, there are no transactions involving the Company and Ms.
Read the 8-K filing - Jul 6, 2020
On July 6, 2020, The Cooper Companies, Inc. (the “Company”) announced that Robert D. Auerbach, M.D., President of CooperSurgical, Inc. (“CooperSurgical”), is retiring. On July 1, 2020, the Company entered into a Transition and Retirement Agreement (the “Agreement”), effective July 8, 2020, with Dr. Auerbach, which provides for his resignation as President of CooperSurgical, effective July 13, 2020. Dr. Auerbach will remain at the Company as Special Advisor to the Chief Executive Officer until his retirement on February 1, 2021, to ensure a smooth transition and to assist with special projects. The Agreement provides that Dr. Auerbach will continue to receive his current salary through February 1, 2021 and will remain eligible for his performance bonus for fiscal 2020 under the Company’s Incentive Payment Plan. The Agreement also provides that Dr.
Read the 8-K filing - Dec 16, 2019
2020 Incentive Payment Plan On December 10, 2019, the Organization and Compensation Committee (the “Committee”) of the Board of Directors of The Cooper Companies, Inc. (“Cooper”) approved the 2020 Incentive Payment Plan (the “2020 IPP”) for Cooper and its subsidiaries (collectively with Cooper, the “Company”) which provides cash incentive opportunities for named executive officers and other executives as a percentage of base salaries, performance goals relating to the operating business’ (CooperVision’s or CooperSurgical’s) or the Company’s consolidated results (depending upon the named participant’s area of responsibility). The above summary of the 2020 IPP is qualified in its entirety by the copy of such plan attached hereto as Exhibit 10.1 and incorporated herein by reference.
Read the 8-K filing - Apr 18, 2019
On April 17, 2019, The Cooper Companies, Inc. (the “ Company ”) entered into executive employment agreements with each of Albert G. White III, President and Chief Executive Officer, Brian G. Andrews, Senior Vice President, Chief Financial Officer and Treasurer, Daniel G. McBride, Executive Vice President and Chief Operating Officer and President of CooperVision, Inc., Holly R. Sheffield, Executive Vice President and Chief Strategy Officer, and Robert D. Auerbach, M.D., President of CooperSurgical, Inc., each of which is effective as of November 1, 2018 and supersedes in their entirety any prior employment, severance or change in control arrangement with the Company.
Read the 8-K filing - May 2, 2018
As previously disclosed in a Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on March 9, 2018, Albert G. White, III has been named by the Board of Directors (the “Board”) of The Cooper Companies, Inc. (the “Company”) as the President and Chief Executive Officer (“CEO”) of the Company, effective May 1, 2018. In connection with Mr. White’s appointment as President and CEO of the Company, he was also elected to the Board, effective May 1, 2018. Effective May 1, 2018, the Board set his annual base salary at $800,000 plus an annual bonus targeted at 100% of his annual base salary. Effective May 1, 2018, Mr. White was also awarded a one-time grant of options to purchase 34,479 shares of our common stock with an exercise price of $230.09 per share, equal to the closing market price of the common stock on the date of grant.
Read the 8-K filing - Apr 23, 2018
Appointment of Certain Officers. On April 23, 2018, The Cooper Companies, Inc. (“Cooper”) announced that Brian Andrews has been promoted to Senior Vice President, Chief Financial Officer and Treasurer of The Cooper Companies effective May 1, 2018. Mr. Andrews will succeed Albert White as Chief Financial Officer who, as previously announced, will assume the role of President and Chief Executive Officer on May 1, 2018. Brian began his career at Cooper in 2006 as Assistant Treasurer and served in that role until 2013 when he was promoted to Treasurer. He was promoted to Vice President in 2015 and added the role of Vice President, Global Logistics and Service for CooperSurgical in 2017. Prior to joining Cooper, he held various corporate and investment banking positions at KeyBanc Capital Markets and at ING Barings.
Read the 8-K filing - Apr 16, 2018
On April 10, 2018, The Cooper Companies, Inc. (the “Company”) entered into a Separation Agreement and Mutual Release (the “Agreement”), effective April 18, 2018, with Carol R. Kaufman, which provides for her resignation as Executive Vice President, Secretary, Chief Administrative Officer and Chief Governance Officer, effective April 30, 2018. Ms. Kaufman will remain employed by the Company as an advisor through December 31, 2018 when she retires. The Agreement provides that Ms. Kaufman will continue to receive her current salary through December 31, 2018. The Agreement also provides that Ms. Kaufman will receive a payment of $711,810.60 on or before March 15, 2019. The Agreement also provides that the Company will pay Ms.
Read the 8-K filing - Mar 9, 2018
On March 8, 2018, The Cooper Companies, Inc. (the “Company”) announced that its Board of Directors (its “Board”) has named Albert G. White III as the President and Chief Executive Officer (“CEO”) of the Company, effective May 1, 2018. Mr. White will succeed Robert S. Weiss, who will retire as President and CEO, effective April 30, 2018. Mr. White, 49, has served as Chief Financial Officer since November 2016. He also serves as Executive Vice President and Chief Strategy Officer, positions he has held since December 2015 and July 2011, respectively. Since August 2015, Mr. White also oversees and directs our women’s healthcare business and is currently CEO of Cooper Medical, Inc., the parent company to CooperSurgical, Inc.
Read the 8-K filing - Nov 1, 2017
Appointment of Chief Accounting Officer The Board of Directors of The Cooper Companies, Inc. (the “Company” or “Cooper”) has appointed Mr. Agostino Ricupati to the position of Chief Accounting Officer as of October 26, 2017, to serve in such capacity until his earlier resignation or removal, or until his successor has been duly appointed and assigned. This title will be held in addition to his current service as Senior Vice President, Finance & Tax, which he was appointed to in July 2017. Mr. Ricupati previously served as Vice President, Tax for the Company from July 2013 to July 2017. Prior to joining Cooper, he served as International Tax Director for Intel Corp. (NASDAQ: INTC) from 2010 to 2013 and in various other senior finance and tax positions over the past 20 years. He holds a master degree from DePaul University and is a Certified Public Accountant.
Read the 8-K filing - Jan 13, 2017
Departure of Director or Certain Officer. Tina Maloney, Corporate Controller and Principal Accounting Officer, will leave the Company on January 23, 2017.
Read the 8-K filing - Sep 1, 2016
Appointment of Certain Officers. On September 1, 2016, The Cooper Companies, Inc. (the “Company”) announced that Gregory W. Matz, 57, Senior Vice President, Chief Financial Officer and Chief Risk Officer, will retire effective October 31, 2016. He will remain at the Company until the end of March 2017 to ensure a smooth transition. Mr. Matz served as Senior Vice President since November 2014, as Chief Risk Officer since November 2013 and as Chief Financial Officer since December 2011. Previously he served as Vice President, Finance from July 2011 to December 2011. The Company also announced that Albert G. White, III, 47, will be appointed Chief Financial Officer in addition to his current responsibilities as the Company’s Executive Vice President and Chief Strategy Officer, effective November 1, 2016. Mr.
Read the 8-K filing - Apr 4, 2016
Director or officer change (Item 5.02). Open the filing for details.
Read the 8-K filing
Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021
Share price
Annual financials
From the company's 10-K XBRL data (SEC companyfacts).
| Fiscal year | Revenue | Net income | Margin | Diluted EPS | Total assets |
|---|---|---|---|---|---|
| FY2025 | $4.1B | $374.9M | 9.2% | $1.87 | $12.4B |
| FY2024 | $3.9B | $392.3M | 10.1% | $1.96 | $12.3B |
| FY2023 | $3.6B | $294.2M | 8.2% | $1.48 | $11.7B |
| FY2022 | $3.3B | $385.8M | 11.7% | $1.94 | $11.5B |
| FY2021 | $2.9B | $2.9B | 100.8% | $59.16 | $9.6B |
| FY2020 | $2.4B | $238.4M | 9.8% | $4.81 | $6.7B |
| FY2019 | $2.7B | $466.7M | 17.6% | $9.33 | $6.3B |
| FY2018 | $2.5B | $139.9M | 5.5% | $2.81 | $6.1B |
Former directors and officers (17)
People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.